Physician profile
Ashley Evon Garibaldi
NPI 1760724884
$1,732.94
in general payments reported to CMS, 2019-2025
19 companies · $155 in 2025
The $155 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $100 · 2022: $367 · 2023: $518 · 2024: $342 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,015.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,015.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $276.99 | 2024 | Inspire |
| Novo Nordisk INC | $268.26 | 2022-2023 | Ozempic, Rybelsus |
| Janssen Scientific Affairs, LLC | $231.45 | 2022-2023 | Xarelto |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Abbott Laboratories | $121.70 | 2022 | |
| Sanofi-Aventis U.S. LLC | $116.45 | 2023-2025 | |
| Amgen INC. | $115.69 | 2023 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $100.00 | 2020 | |
| Cranial Technologies, INC | $98.42 | 2019-2025 | Doc Band |
| Corium, LLC | $91.47 | 2022-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $37.10 | 2019-2022 | |
| Tris Pharma INC | $33.23 | 2019 | |
| Pfizer INC. | $28.52 | 2019 | |
| Acadia Pharmaceuticals INC | $19.82 | 2024 | Daybue |
| Ars Pharmaceuticals Operations, INC. | $15.71 | 2025 | Neffy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $14.81 | 2025 | Zelsuvmi |
| Teva Pharmaceuticals USA, INC. | $14.43 | 2019 | |
| Ironshore Pharmaceuticals INC. | $13.02 | 2019 | |
| Sanofi Pasteur INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Garibaldi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.